To demonstrate whether IFN-γ or TNF-α priming can grant TMSCs beneficial preventive and therapeutic potency in vivo, we utilized a DSS-induced murine colitis model that T cell- and macrophage-mediated immune responses play a critical role in the disease pathogenesis. The gene discussed is IFNG; the disease is colitis.